| Qendresa Hasani, PHARMD | |
|
706 E Seltice Way, Post Falls, ID 83854-8674 | |
| (208) 777-4071 | |
| Not Available |
| Full Name | Qendresa Hasani |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 706 E Seltice Way, Post Falls, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003510280 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | P10538 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Qendresa Hasani, PHARMD 20748 E Valley Vista Dr, Liberty Lake, WA 99019-6058 Ph: () - | Qendresa Hasani, PHARMD 706 E Seltice Way, Post Falls, ID 83854-8674 Ph: (208) 777-4071 |
News Archive
NPR continues its coverage of issues being discussed at the XIX International AIDS Conference (AIDS 2012) with several stories on its health blog and radio programs. On Thursday, "Tell Me More" host Michel Martin spoke with Teguest Guerma, the first woman director general of the African Medical and Research Fund (AMREF) about how African nations are responding to the HIV/AIDS epidemic and how they are working "to find the solutions ourselves, with the support of the international community," Guerma said, according to the program's transcript.
Boehringer Ingelheim Pharmaceuticals, Inc. today announced that enrollment has commenced at North American sites in its pivotal Phase 3 clinical trial program for BI 201335, the Company's investigational, oral protease inhibitor for the treatment of chronic hepatitis C virus (HCV).
People with celiac disease are at risk for osteoporosis, according to physicians at Loyola University Health System (LUHS). A 2009 New England Journal of Medicine study supports this correlation. Researchers believe that people with celiac disease may develop osteoporosis because their body poorly absorbs calcium and vitamin D, which are necessary for bone health.
Patients with advanced lung adenocarcinoma who produce the XAGE1 antibody appear to survive twice as long as those who do not produce it, Japanese study data show.
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, and Tarrot Laboratories, a business unit of Cedars-Sinai Medical Center, today announced the execution of an exclusive research collaboration and license agreement. The collaboration will focus on identifying genetic or serologic markers associated with clinical responses to anti-TNF therapies such as Cimzia, Humira and Remicade utilized in the treatment of Crohn's Disease, and the subsequent development of diagnostic tests.
› Verified 1 days ago
Chaney M Boyle, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 802 E Medical Ct, Post Falls, ID 83854 Phone: 208-773-3566 | |
Kathlene Elizabeth Bailey, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3050 E Mullan Ave, Post Falls, ID 83854 Phone: 208-777-4502 Fax: 208-777-8033 | |
Jacqueline L Groat, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3372 E Jenalan, Post Falls, ID 83854 Phone: 208-262-8751 | |
Suzanne Wakefield, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 706 E Seltice Way, Post Falls, ID 83854 Phone: 208-777-4071 Fax: 208-773-0913 | |
Mkcade Knox Eilmann, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 N Cecil Rd, Post Falls, ID 83854 Phone: 208-262-2788 | |
M George Crawford, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3050 E Mullan Ave, Post Falls, ID 83854 Phone: 208-777-4502 |